The Ph.D. program at Gallaudet University prepares scholars and practitioners to lead in the design, development, and ...
The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic ...
This potentially valuable cross-sectional longitudinal study leverages high-definition transcranial direct current stimulation to the left dorsolateral prefrontal cortex to examine its effect on ...
Introduction People with epilepsy are at higher risk for hypertension, diabetes, hyperlipidaemia and obesity than the US general population. It is unknown whether these risk factors translate to ...
Now, gearing up for his 100th Test, Mushfiqur is among the only three cricketers to have a 20-year-long Test career after making their debut in the 2000s, alongside James Anderson and Brendan Taylor.
Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater State University and helps develop content strategies. Regression analysis ...
This study presents a large, systematically curated catalog of non-canonical open reading frames (ncORFs) in human and mouse by reanalyzing nearly 400 Ribo-seq datasets using a standardized pipeline; ...
T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory ...
Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Food intolerances, food sensitivities, and food allergies can all produce negative symptoms, ranging from undesirable to downright dangerous. Food intolerances can produce uncomfortable or ...
News Medical on MSN
Tec-Dara could represent a new standard of care for relapsed or refractory multiple myeloma
Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results